Indication

Pulmonary aspergillosis

Pulmonary aspergillosis refers to a diverse spectrum of respiratory infections and inflammatory conditions caused by the inhalation of environmental spores from *Aspergillus* species, most commonly *Aspergillus fumigatus*. Read more about Pulmonary aspergillosis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Pulmonary aspergillosis therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Pulmonary aspergillosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pulmonary aspergillosis.

Pulmonary aspergillosis refers to a diverse spectrum of respiratory infections and inflammatory conditions caused by the inhalation of environmental spores from *Aspergillus* species, most commonly *Aspergillus fumigatus*.

Pathophysiologically, the disease manifestations depend on host immune status and preexisting lung architecture, encompassing allergic bronchopulmonary aspergillosis in atopic individuals, chronic cavitary infections or aspergillomas in pre-damaged lung tissue, and angioinvasive necrosis in severely immunocompromised hosts.

Affected populations frequently present with nonspecific lower respiratory symptoms, including persistent cough, fever, dyspnea, wheezing, and hemoptysis, alongside characteristic radiologic findings such as pulmonary infiltrates, nodules, or intracavitary fungal balls.

Personalize your experience

Follow Pulmonary aspergillosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it